Phylogenetic structure in African HIV-1 subtype C revealed by selective sequential pruning

Virology

Volumn 415, Issue 1, 2011, Pages 30-38

  Thomson, Michael M ^a   Fernández García, Aurora ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Africa; Clusters; HIV 1; Phylogeny; South Africa; Subtype C

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; CLADISTICS; GENE CLUSTER; GENETIC RECOMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHYLOGENETIC TREE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; SOUTH AFRICA; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS TRANSMISSION; VIRUS TYPING;

AFRICA; AIDS VACCINES; BASE SEQUENCE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; RECOMBINATION, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79956193969     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.021     Document Type: Article

References (78)

1. Abebe A., Pollakis G., Fontanet A.L., Fisseha B., Tegbaru B., Kliphuis A., Tesfaye G., Negassa H., Cornelissen M., Goudsmit J., Rinke de Wit T.F. Identification of a genetic subcluster of HIV type 1 subtype C (C') widespread in Ethiopia. AIDS Res. Hum. Retroviruses 2000, 16:1909-1914.
2. Abrahams M.R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.H., Athreya G.S., Treurnicht F.K., Keele B.F., Wood N., Salazar-Gonzalez J.F., Bhattacharya T., Chu H., Hoffman I., Galvin S., Mapanje C., Kazembe P., Thebus R., Fiscus S., Hide W., Cohen M.S., Karim S.A., Haynes B.F., Shaw G.M., Hahn B.H., Korber B.T., Swanstrom R., Williamson C. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J. Virol. 2009, 83:3556-3567.
3. Ahumada-Ruiz S., Flores-Figueroa D., Toala-González I., Thomson M.M. Analysis of HIV-1 pol sequences from Panama: identification of phylogenetic clusters within subtype B and detection of antiretroviral drug resistance mutations. Infect. Genet. Evol. 2009, 9:933-940.
4. Altfeld M., Allen T.M. Hitting HIV where it hurts: an alternative approach to HIV vaccine design. Trends Immunol. 2006, 27:504-510.
5. Anisimova M., Gascuel O. Approximate likelihood-ratio test for branches: a fast, accurate, and powerful alternative. Syst. Biol. 2006, 55:539-552.
6. Archer J., Robertson D.L. Understanding the diversification of HIV-1 groups M and O. AIDS 2007, 21:1693-1700.
7. Arenas M., Posada D. Computational design of centralized HIV-1 genes. Curr. HIV Res. 2010, 8:613-621.
8. Barouch D.H., O'Brien K.L., Simmons N.L., King S.L., Abbink P., Maxfield L.F., Sun Y.H., La Porte A., Riggs A.M., Lynch D.M., Clark S.L., Backus K., Perry J.R., Seaman M.S., Carville A., Mansfield K.G., Szinger J.J., Fischer W., Muldoon M., Korber B. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat. Med. 2010, 16:319-323.
9. Bello G., Passaes C.P., Guimaraes M.L., Lorete R.S., Matos Almeida S.E., Medeiros R.M., Alencastro P.R., Morgado M.G. Origin and evolutionary history of HIV-1 subtype C in Brazil. AIDS 2008, 22:1993-2000.
10. Bergsten J. A review of long-branch attraction. Cladistics 2005, 21:163-193.
11. Binley J.M., Wrin T., Korber B., Zwick M.B., Wang M., Chappey C., Stiegler G., Kunert R., Zolla-Pazner S., Katinger H., Petropoulos C.J., Burton D.R. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 2004, 78:13232-13252.
12. Blish C.A., Jalalian-Lechak Z., Rainwater S., Nguyen M.A., Dogan O.C., Overbaugh J. Cross-subtype neutralization sensitivity despite monoclonal antibody resistance among early subtype A, C, and D envelope variants of human immunodeficiency virus type. J. Virol. 2009, 83:7783-7788.
13. Bredell H., Martin D.P., Van Harmelen J., Varsani A., Sheppard H.W., Donovan R., Gray C.M., Williamson C. HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res. Hum. Retroviruses 2007, 23:477-481.
14. Brown B.K., Wieczorek L., Sanders-Buell E., Rosa B.A., Robb M.L., Birx D.L., Michael N.L., McCutchan F.E., Polonis V.R. Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology 2008, 375:529-538.
15. Bures R., Morris L., Williamson C., Ramjee G., Deers M., Fiscus S.A., Abdool-Karim S., Montefiori D.C. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. J. Virol. 2002, 76:2233-2244.
16. Cao H., Mani I., Vincent R., Mugerwa R., Mugyenyi P., Kanki P., Ellner J., Walker B.D. Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda. J. Infect. Dis.182 2000, 1350-1356.
17. Coplan P.M., Gupta S.B., Dubey S.A., Pitisuttithum P., Nikas A., Mbewe B., Vardas E., Schechter M., Kallas E.G., Freed D.C., Fu T.M., Mast C.T., Puthavathana P., Kublin J., Brown C.K., Chisi J., Pendame R., Thaler S.J., Gray G., Mcintyre J., Straus W.L., Condra J.H., Mehrotra D.V., Guess H.A., Emini E.A., Shiver J.W. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J. Infect. Dis. 2005, 191:1427-1434.
18. Craigo J.K., Zhang B., Barnes S., Tagmyer T.L., Cook S.J., Issel C.J., Montelaro R.C. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proc. Natl. Acad. Sci. USA 2007, 104:15105-15110.
19. Cranston K.A., Rannala B. Summarizing a posterior distribution of trees using agreement subtrees. Syst. Biol. 2007, 56:578-590.
20. Currier J.R., Dowling W.E., Wasunna K.M., Alam U., Mason C.J., Robb M.L., Carr J.K., McCutchan F.E., Birx D.L., Cox J.H. Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans. AIDS 2003, 17:2149-2157.
21. Gao F., Liao H.X., Hahn B.H., Letvin N.L., Korber B.T., Haynes B.F. Centralized HIV-1 envelope immunogens and neutralizing antibodies. Curr. HIV Res. 2007, 5:572-577.
22. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., Korber B. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296:2354-2360.
23. Geldmacher C., Currier J.R., Gerhardt M., Haule A., Maboko L., Birx D., Gray C., Meyerhans A., Cox J., Hoelscher M. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype. AIDS 2007, 21:135-143.
24. Guindon S., Lethiec F., Duroux P., Gascuel O. PHYML Online-a web server for fast maximum likelihood-based phylogenetic inference. Nucleic Acids Res. 2005, 33:W557-W559.
25. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59:307-321.
26. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011, 25:679-689. WHO-UNAIDS Network for HIV Isolation and Characterisation.
27. HIV Sequence Database Available at, Last accessed November 6, 2010. http://www.hiv.lanl.gov/.
28. Katoh K., Asimenos G., Toh H. Multiple alignment of DNA sequences with MAFFT. Meth. Mol. Biol. 2009, 537:39-64.
29. Kodandaramaiah U., Pena C., Braby M.F., Grund R., Muller C.J., Nylin S., Wahlberg N. Phylogenetics of Coenonymphina (Nymphalidae: Satyrinae) and the problem of rooting rapid radiations. Mol. Phylogenet. Evol. 2010, 54:386-394.
30. Korber B., Muldoon M., Theiler J., Gao F., Gupta R., Lapedes A., Hahn B., Wolinsky S., Bhattacharya T. Timing the ancestor of the HIV-1 pandemic strains. Science 2000, 288:1789-1796.
31. Kostrikis L.G., Cao Y., Ngai H., Moore J.P., Ho D.D. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. J. Virol. 1996, 70:445-458.
32. Letourneau S., Im E.J., Mashishi T., Brereton C., Bridgeman A., Yang H., Dorrell L., Dong T., Korber B., McMichael A.J., Hanke T. Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS ONE 2007, 2:e984.
33. Li M., Salazar-Gonzalez J.F., Derdeyn C.A., Morris L., Williamson C., Robinson J.E., Decker J.M., Li Y., Salazar M.G., Polonis V.R., Mlisana K., Karim S.A., Hong K., Greene K.M., Bilska M., Zhou J., Allen S., Chomba E., Mulenga J., Vwalika C., Gao F., Zhang M., Korber B.T., Hunter E., Hahn B.H., Montefiori D.C. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 2006, 80:11776-11790.
34. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 1999, 73:152-160.
35. Lu S., Wang S., Grimes Serrano J.M. Polyvalent AIDS vaccines. Curr. HIV Res. 2010, 8:622-629.
36. Mascola J.R., Louwagie J., McCutchan F.E., Fischer C.L., Hegerich P.A., Wagner K.F., Fowler A.K., McNeil J.G., Burke D.S. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J. Infect. Dis. 1994, 169:48-54.
37. Mascola J.R., Louder M.K., Surman S.R., Vancott T.C., Yu X.F., Bradac J., Porter K.R., Nelson K.E., Girard M., McNeil J.G., McCutchan F.E., Birx D.L., Burke D.S. Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res. Hum. Retroviruses 1996, 12:1319-1328.
38. McKinnon L.R., Ball T.B., Kimani J., Wachihi C., Matu L., Luo M., Embree J., Fowke K.R., Plummer F.A. Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J. Acquir. Immune Defic. Syndr. 2005, 40:245-249.
39. Miller, M.A., Holder, M.T., Vos, R., Midford, P.E., Liebowitz, T., Chan, L., Hoover, P., Warnow, T., The CIPRES Portals. URL:http://www.phylo.org/sub_sections/portal.
40. Moore J.P., Cao Y., Leu J., Qin L., Korber B., Ho D.D. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 1996, 70:427-444.
41. Nickle D.C., Jensen M.A., Gottlieb G.S., Shriner D., Learn G.H., Rodrigo A.G., Mullins J.I. Consensus and ancestral state HIV vaccines. Science 2003, 299:1515-1518.
42. Novitsky V.A., Montano M.A., McLane M.F., Renjifo B., Vannberg F., Foley B.T., Ndung'u T.P., Rahman M., Makhema M.J., Marlink R., Essex M. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J. Virol. 1999, 73:4427-4432.
43. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., Essex M. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 2002, 76:5435-5451.
44. Novitsky V., Wang R., Lagakos S., Essex M. HIV-1 subtype C phylodynamics in the global epidemic. Viruses 2010, 2:33-54.
45. Nyambi P.N., Nkengasong J., Lewi P., Andries K., Janssens W., Fransen K., Heyndrickx L., Piot P., van der G.G. Multivariate analysis of human immunodeficiency virus type 1 neutralization data. J. Virol. 1996, 70:6235-6243.
46. Philippe H., Laurent J. How good are deep phylogenetic trees?. Curr. Opin. Genet. Dev. 1998, 8:616-623.
47. Pollakis G., Abebe A., Kliphuis A., De Wit T.F., Fisseha B., Tegbaru B., Tesfaye G., Negassa H., Mengistu Y., Fontanet A.L., Cornelissen M., Goudsmit J. Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. AIDS Res. Hum. Retroviruses 2003, 19:999-1008.
48. Price M.N., Dehal P.S., Arkin A.P. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS ONE 2010, 5:e9490.
49. Pyron R.A., Burbrink F.T., Colli G.R., de Oca A.N., Vitt L.J., Kuczynski C.A., Wiens J.J. The phylogeny of advanced snakes (Colubroidea), with discovery of a new subfamily and comparison of support methods for likelihood trees. Mol. Phylogenet. Evol. 2011, 58:329-342.
50. Rambaut A., Robertson D.L., Pybus O.G., Peeters M., Holmes E.C. Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 2001, 410:1047-1048.
51. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., Benenson M., Gurunathan S., Tartaglia J., McNeil J.G., Francis D.P., Stablein D., Birx D.L., Chunsuttiwat S., Khamboonruang C., Thongcharoen P., Robb M.L., Michael N.L., Kunasol P., Kim J.H. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209-2220.
52. Rolland M., Nickle D.C., Mullins J.I. HIV-1 group M conserved elements vaccine. PLoS Pathog. 2007, 3:e157.
53. Ronquist F., Huelsenbeck J.P. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19:1572-1574.
54. Rousseau C.M., Learn G.H., Bhattacharya T., Nickle D.C., Heckerman D., Chetty S., Brander C., Goulder P.J., Walker B.D., Kiepiela P., Korber B.T., Mullins J.I. Extensive intrasubtype recombination in South African human immunodeficiency virus type 1 subtype C infections. J. Virol. 2007, 81:4492-4500.
55. Sanabani S., Neto W.K., Sa Filho D.J., Diaz R.S., Munerato P., Janini L.M., Sabino E.C. Full-length genome analysis of human immunodeficiency virus type 1 subtype C in Brazil. AIDS Res. Hum. Retroviruses 2006, 22:171-176.
56. Seaman M.S., Janes H., Hawkins N., Grandpre L.E., Devoy C., Giri A., Coffey R.T., Harris L., Wood B., Daniels M.G., Bhattacharya T., Lapedes A., Polonis V.R., McCutchan F.E., Gilbert P.B., Self S.G., Korber B.T., Montefiori D.C., Mascola J.R. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J. Virol. 2010, 84:1439-1452.
57. Shankarappa R., Chatterjee R., Learn G.H., Neogi D., Ding M., Roy P., Ghosh A., Kingsley L., Harrison L., Mullins J.I., Gupta P. Human immunodeficiency virus type 1 env sequences from Calcutta in eastern India: identification of features that distinguish subtype C sequences in India from other subtype C sequences. J. Virol. 2001, 75:10479-10487.
58. Shavit L., Penny D., Hendy M.D., Holland B.R. The problem of rooting rapid radiations. Mol. Biol. Evol. 2007, 24:2400-2411.
59. Simek M.D., Rida W., Priddy F.H., Pung P., Carrow E., Laufer D.S., Lehrman J.K., Boaz M., Tarragona-Fiol T., Miiro G., Birungi J., Pozniak A., McPhee D.A., Manigart O., Karita E., Inwoley A., Jaoko W., Dehovitz J., Bekker L.G., Pitisuttithum P., Paris R., Walker L.M., Poignard P., Wrin T., Fast P.E., Burton D.R., Koff W.C. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J. Virol. 2009, 83:7337-7348.
60. Soares M.A., De Oliveira T., Brindeiro R.M., Diaz R.S., Sabino E.C., Brigido L., Pires I.L., Morgado M.G., Dantas M.C., Barreira D., Teixeira P.R., Cassol S., Tanuri A. A specific subtype C of human immunodeficiency virus type 1 circulates in Brazil. AIDS 2003, 17:11-21.
61. Sperling E.A., Peterson K.J., Pisani D. Phylogenetic-signal dissection of nuclear housekeeping genes supports the paraphyly of sponges and the monophyly of Eumetazoa. Mol. Biol. Evol. 2009, 26:2261-2274.
62. Stamatakis A., Hoover P., Rougemont J. A rapid bootstrap algorithm for the RAxML Web servers. Syst. Biol. 2008, 57:758-771.
63. Stiller J.W., Hall B.D. Long-branch attraction and the rDNA model of early eukaryotic evolution. Mol. Biol. Evol. 1999, 16:1270-1279.
64. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.05. Mol. Biol. Evol. 2007, 24:1596-1599.
65. Thomson M.M., Villahermosa M.L., Vázquez de Parga E., Cuevas M.T., Delgado E., Manjón N., Medrano L., Pérez-Álvarez L., Contreras G., Carrillo M.G., Salomón H., Nájera R. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina. AIDS 2000, 14:897-899.
66. Thomson M.M., Nájera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev. 2005, 7:210-224.
67. Thomson M.M., Vinogradova A., Delgado E., Rakhmanova A., Yakovlev A., Cuevas M.T., Muñoz M., Pinilla M., Vega Y., Pérez-Álvarez L., Osmanov S., Nájera R. Molecular epidemiology of HIV-1 in St Petersburg, Russia: predominance of subtype A, former Soviet Union variant, and identification of intrasubtype subclusters. J. Acquir. Immune Defic. Syndr. 2009, 51:332-339.
68. Thorley J.L., Wilkinson M. Testing the phylogenetic stability of early tetrapods. J. Theor. Biol. 1999, 200:343-344.
69. Treurnicht F.K., Seoighe C., Martin D.P., Wood N., Abrahams M.R., Rosa D.A., Bredell H., Woodman Z., Hide W., Mlisana K., Karim S.A., Gray C.M., Williamson C. Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. Virology 2010, 396:213-225.
70. van Gils M.J., Edo-Matas D., Schweighardt B., Wrin T., Schuitemaker H. High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity. J. Gen. Virol. 2010, 91:250-258.
71. Walker L.M., Burton D.R. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 2010, 22:358-366.
72. Weber J., Fenyo E.M., Beddows S., Kaleebu P., Bjorndal A. Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization. J. Virol. 1996, 70:7827-7832.
73. Wiens J.J., Kuczynski C.A., Smith S.A., Mulcahy D.G., Sites J.W., Townsend T.M., Reeder T.W. Branch lengths, support, and congruence: testing the phylogenomic approach with 20 nuclear loci in snakes. Syst. Biol. 2008, 57:420-431.
74. Wilkinson M. Majority-rule reduced consensus trees and their use in bootstrapping. Mol. Biol. Evol. 1996, 13:437-444.
75. Worobey M., Gemmel M., Teuwen D.E., Haselkorn T., Kunstman K., Bunce M., Muyembe J.J., Kabongo J.M., Kalengayi R.M., Van Marck E., Gilbert M.T., Wolinsky S.M. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008, 455:661-664.
76. Xiao X., Chen W., Feng Y., Zhu Z., Prabakaran P., Wang Y., Zhang M.Y., Longo N.S., Dimitrov D.S. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 2009, 390:404-409.
77. Zhou T., Georgiev I., Wu X., Yang Z.Y., Dai K., Finzi A., Kwon Y.D., Scheid J.F., Shi W., Xu L., Yang Y., Zhu J., Nussenzweig M.C., Sodroski J., Shapiro L., Nabel G.J., Mascola J.R., Kwong P.D. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 2010, 329:811-817.
78. Zhu T., Korber B.T., Nahmias A.J., Hooper E., Sharp P.M., Ho D.D. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998, 391:591-594.